Literature DB >> 17552054

The Academic Medical Center Linear Disability Score item bank: psychometric properties of a new generic disability measure in rheumatoid arthritis.

Nadine Weisscher1, Carla A Wijbrandts, Rob de Haan, Cees A W Glas, Marinus Vermeulen, Paul Peter Tak.   

Abstract

OBJECTIVE: To determine the psychometric properties of the Academic Medical Center (AMC) Linear Disability Scale (ALDS) item bank in a population of patients with rheumatoid arthritis (RA).
METHODS: 129 patients with RA completed the ALDS and Health Assessment Questionnaire Disability Index (HAQ-DI) at baseline, and after 8 and 16 weeks of anti-tumor necrosis factor-alpha treatment. Disease activity assessments at these timepoints included serum levels of C-reactive protein, Disease Activity Score 28, morning stiffness, and visual analog scales for global disease activity and fatigue.
RESULTS: Reliability of the ALDS was excellent (homogeneity, Cronbach's alpha = 0.95; test-retest, intraclass correlation coefficient = 0.93). The ALDS results at baseline were strongly correlated with the HAQ-DI (r = -0.75). With regard to known group validity, both instruments discriminated between higher and lower disease activity (ALDS, p < 0.0001; HAQ-DI, p = 0.002) and between non-, moderate, and good responders (ALDS, p = 0.002; HAQ-DI, p < 0.0001), indicating that both instruments differentiate between groups. The ALDS was moderately to highly responsive to changes between baseline and after 8 weeks and 16 weeks of treatment (standardized response mean, range = 0.71-1.19). No substantial floor or ceiling effects were found.
CONCLUSION: Our results show that the ALDS is a promising new instrument, with at least equivalent psychometric properties compared to the HAQ-DI. Advantages of the ALDS item bank are its linear structure and an item bank that can be adapted depending on the ability level of the patient.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17552054

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  5 in total

1.  What should be defined as good outcome in stroke trials; a modified Rankin score of 0-1 or 0-2?

Authors:  N Weisscher; M Vermeulen; Y B Roos; R J de Haan
Journal:  J Neurol       Date:  2008-03-14       Impact factor: 4.849

2.  Validation of the Dutch version of the VascuQol questionnaire and the Amsterdam Linear Disability Score in patients with intermittent claudication.

Authors:  Franceline Alkine Frans; Suzanne E van Wijngaarden; Rosemarie Met; Mark J W Koelemay
Journal:  Qual Life Res       Date:  2011-11-15       Impact factor: 4.147

3.  The Academic Medical Center Linear Disability Score for evaluation of physical reserve on admission to the ICU: can we query the relatives?

Authors:  José G M Hofhuis; Marcel G W Dijkgraaf; Aly Hovingh; Richard L Braam; Lisa van de Braak; Peter E Spronk; Johannes H Rommes
Journal:  Crit Care       Date:  2011-09-14       Impact factor: 9.097

4.  Assessment of disability in idiopathic inflammatory myopathy: a call for linearity.

Authors:  Minoesch Min; Anne W Walter; Johan Lim; Filip Eftimov; Camiel Verhamme; Marianne de Visser; Ivo N van Schaik; Rohit Aggarwal; Rob J de Haan; Anneke J van der Kooi; Joost Raaphorst
Journal:  Rheumatology (Oxford)       Date:  2022-08-03       Impact factor: 7.046

5.  The AMC linear disability score (ALDS): a cross-sectional study with a new generic instrument to measure disability applied to patients with peripheral arterial disease.

Authors:  Rosemarie Met; Jim A Reekers; Mark J W Koelemay; Dink A Legemate; Rob J de Haan
Journal:  Health Qual Life Outcomes       Date:  2009-10-12       Impact factor: 3.186

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.